Searched over 200M research papers
10 papers analyzed
These studies suggest angiotensin 2 plays a crucial role in blood pressure regulation, cardiovascular protection, and sodium excretion, with implications for treating hypertension and other cardiovascular diseases.
20 papers analyzed
Angiotensin II (Ang II) is a critical peptide in the renin-angiotensin system (RAS), which regulates blood pressure, fluid balance, and electrolyte homeostasis. Ang II exerts its effects primarily through two receptor subtypes: the angiotensin type 1 receptor (AT1R) and the angiotensin type 2 receptor (AT2R) .
The AT1R is the primary mediator of Ang II's classical functions, including vasoconstriction, which leads to increased blood pressure. This receptor also stimulates renal tubular sodium reabsorption, contributing to fluid retention and further elevating blood pressure .
AT1R activation promotes cell proliferation, inflammation, and oxidative stress. These actions are significant in the pathophysiology of cardiovascular diseases, as they contribute to vascular remodeling and hypertrophy .
In contrast to AT1R, the AT2R often opposes the actions of AT1R. It inhibits cell proliferation, promotes cell differentiation, and induces vasodilation and natriuresis (excretion of sodium in urine), thus counteracting the vasoconstrictive and antinatriuretic effects of AT1R .
AT2R mediates its effects through different signaling pathways, including the activation of bradykinin, nitric oxide (NO), and cyclic GMP (cGMP) pathways. These pathways lead to vasodilation and reduced blood pressure . Additionally, AT2R activation can inhibit the Na+/H+ exchanger in vascular smooth muscle cells, promoting intracellular acidosis and further enhancing vasodilation.
ACE2 is a crucial enzyme that converts Ang II to Angiotensin-(1-7) . Ang-(1-7) has vasodilatory and anti-proliferative effects, opposing the actions of Ang II. This conversion represents a feedforward mechanism that mitigates the adverse effects of Ang II .
ACE2 has protective roles in cardiovascular diseases by reducing oxidative stress, enhancing baroreflex sensitivity, and preventing hypertension. Overexpression of ACE2 in specific brain regions has been shown to reduce Ang II-mediated pressor and drinking responses, highlighting its central role in blood pressure regulation .
The therapeutic potential of targeting the RAS, particularly through modulation of ACE2 and AT2R, is significant. ACE2 overexpression and AT2R activation have shown promise in reducing blood pressure and protecting against cardiovascular and renal diseases . The use of AT1R antagonists in combination with AT2R agonists or ACE2 activators could offer a balanced approach to managing hypertension and related pathologies .
Angiotensin II plays a multifaceted role in the regulation of cardiovascular and renal functions through its interactions with AT1R and AT2R. While AT1R mediates vasoconstriction and promotes pathological changes, AT2R and ACE2 provide counter-regulatory mechanisms that protect against these adverse effects. Understanding these dynamics opens new avenues for therapeutic interventions in cardiovascular diseases.
Most relevant research papers on this topic